Immuneering Corp (NASDAQ:IMRX) has a beta value of -0.33 and has seen 0.4 million shares traded in the recent trading session. The company, currently valued
During the last session, Immuneering Corp (NASDAQ:IMRX)’s traded shares were 8.03 million, with the beta value of the company hitting -0.33. At the end of
During the recent session, Immuneering Corp (NASDAQ:IMRX)’s traded shares were 7.22 million, with the beta value of the company hitting -0.33. At the last check
In last trading session, Immuneering Corp (NASDAQ:IMRX) saw 0.4 million shares changing hands with its beta currently measuring -0.33. Company’s recent per share price level
During the last session, Immuneering Corp (NASDAQ:IMRX)’s traded shares were 0.34 million, with the beta value of the company hitting -0.35. At the end of
Immuneering Corp (NASDAQ:IMRX)’s traded shares stood at 1.48 million during the last session, with the company’s beta value hitting -0.43. At the close of trading,
Immuneering Corp (NASDAQ:IMRX)’s traded shares stood at 0.56 million during the latest session, with the company’s beta value hitting -0.43. At the last check today,
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
